AMA recognizes the following companies as the key players who are driving Respiratory Diagnostics market, some of them are 3M (United States), Philips Healthcare (Netherlands), Becton, Dickinson and Company (United States), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Alere Inc. (United States), BioMerieux (France), Bio-Rad Laboratories, Inc. (United States), COSMED srl (Italy) and Philips (Netherlands).
An analyst from AdvanceMarketAnalytics team said: One of the key factors which is trending the market is Technical Progress in Medical Industry and Heavy Investments in Research & Development. Considering the revolutionary changes occurring in this market, there is a growing demand from the use of Respiratory Diagnostics such as Mechanical Tests, OSA Diagnostic Tests, Imaging Tests and Others.
According to the report, some of the important driving forces behind the market growth are Prevalence of Severe Acute Respiratory Syndrome (SARS) Cases
. The primary concern of any business is the reduction of the overall operating cost. The increased need for operating efficiency and meeting regulatory demands at the same time have become major challenges for the original Players, additional restraints impacting market are Highly Priced Surgical Procedures which is continuously seeking attention of Industry Experts and Decision makers.
The study was conducted using primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market study and vendor landscape in addition to a SWOT analysis of the key Players.
Available Customization: List of players that can be included in the study on immediate basis are SDI Diagnostics Inc. (United States), Roche Holding AG (Switzerland) and AireHealth Inc. (United States).